Comments to FDA: Innovative Technology and Switch

Share page:
Docket Number:
FDA-2012-N-0171

Presentation by Scott Melville, president and CEO of CHPA regarding using innovative technologies and other conditions of safe use to expand which drug products can be considered nonprescription.

Download Document
Issues:

Related Posts